Wave Life Sciences Ltd. (WVE)
6.18
+0.04
(+0.65%)
USD |
NASDAQ |
May 20, 16:00
6.26
+0.08
(+1.29%)
After-Hours: 20:00
Wave Life Sciences Profit Margin (Quarterly) : -68.21% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk A/S | 50.15% |
| Eli Lilly & Co. | 37.36% |
| GSK Plc | 24.11% |
| Jazz Pharmaceuticals Plc | 27.42% |
| Merck & Co., Inc. | -26.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.31% |
| Return on Assets | -45.80% |
| Return on Invested Capital | -57.52% |
| Gross Profit Margin (Quarterly) | 93.97% |
| Operating Margin (Quarterly) | -81.83% |
| Return on Net Operating Assets | -551.7% |